MedTrace Logo

Oculusgen (Ologen) Glaucoma MMC Control in Estonia

NCT00524758 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2017-06-27

No results posted yet for this study

Summary

To compare the safety and effectiveness between ologen collagen matrix and mitomycin-C (MMC) in glaucoma surgery.

The ologen collagen matrix implantation procedure is same as traditional trabeculectomy except implant the ologen collagen matrix on the top of sclera flap after one loose stich the sclera flap. The MMC application is as the standard.

Conditions

  • Open Angle Glaucoma
  • Angle Closure Glaucoma
  • Uveitis Glaucoma
  • Young Age Glaucoma
  • Neovascular Glaucoma
  • High Risk Patient

Interventions

DEVICE

ologen (oculusgen) collagen matrix

Implant ologen collagen matrix on the top of sclera flap after loose stiched the sclera flap. The traditional trabeculectomy is performed.

DRUG

MMC in Trabeculectomy

MMC in Trabeculectomy

Sponsors & Collaborators

  • Pro Top & Mediking Company Limited

    lead INDUSTRY

Principal Investigators

  • Kuldar Kaljurand, MD · University of Tartu

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
19 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-07-31
Primary Completion
2011-10-31
Completion
2011-10-31

Countries

  • Estonia

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00524758 on ClinicalTrials.gov